LifeMD Analyst Price Targets - Benzinga

LifeMD Inc

LFMDNASDAQ

Trade with Public

Trade with Public

$2.24

-0.01-0.44%

最終更新: Oct 20, 9:12 AM

$2.24

-0.01-0.44%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

LifeMD Analyst Price Targets

Wall Street analyst price targets and consensus rating for LifeMD (LFMD).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$10Upside to Avg. PT+346.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9
Aug 7, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$10→$9
Aug 6, 2026	B. Riley Securities	William Woods	PT Cut	Buy	$10→$8
Aug 6, 2026	BTIG	David Larsen	PT Cut	Buy	$10→$9
May 26, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$10
May 4, 2026	BTIG	David Larsen	Maintained	Buy	$10
Mar 16, 2026	Mizuho	Steven Valiquette	Upgrade	Neutral→Outperform	$6→$8
Mar 12, 2026	Freedom Broker	Ilya Zubkov	PT Raise	Buy	$8→$10
Mar 11, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$9→$10
Mar 10, 2026	BTIG	David Larsen	Maintained	Buy	$10
Nov 24, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$11→$8
Nov 19, 2025	Keybanc	Scott Schoenhaus	PT Cut	Overweight	$12→$8
Nov 19, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$13→$9
Nov 19, 2025	Mizuho	Steven Valiquette	PT Cut	Neutral	$8→$6
Nov 18, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$14→$8
Nov 18, 2025	B. Riley Securities	William Woods	PT Cut	Buy	$12→$10
Nov 18, 2025	BTIG	David Larsen	PT Cut	Buy	$18→$10
Aug 7, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$14→$13
Aug 6, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$13→$11
Aug 6, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$18→$14

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8

B. Riley Securities analyst William Woods maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $8.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeMD, Lowers Price Target to $9

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

BTIG analyst David Larsen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Benzinga Newsdesk